Our Business Model revolves around the facilitation of licensing & distribution arrangements between leading local and regional companies ("Licensees") and US/Europe/Japan-innovative based pharmaceutical/biotech/medical device companies ("Licensors").
The selected products are manufactured and shipped from the licensor’s plant in a fully finished form in return for an agreed supply price.
The Contribution of the companies in our network (Licensees)
The Benefits for US, Europe and Japan-based Companies (Licensors)
Penetration into fast growing markets
Effective approach to cultural barriers
Proven model by multinational pharmaceutical companies
Low cost of operation and avoidance of fixed costs
Trusted network of partners
Dealing with a one company ("one stop-shop") - The Harel Group
Global Markets represent an attractive business opportunity to innovative companies and the licensing and distribution business model has a proven track record.The Harel Group has formed a unique and trusted network of leading local and regional partners in the Emerging Markets that can add value in a relatively short time through a resource efficient process.